date,title,source
Oct-17-18,Flagship biotech startup leases space from struggling Catabasis,American City Business Journals
Oct-18-18,"Recent Analysis Shows Progenics Pharmaceuticals, Catabasis Pharmaceuticals, Warrior Met Coal, Preformed Line Products, Express, and Sanmina Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Oct-30-18,"Catabasis Pharmaceuticals to Report Third Quarter 2018 Financial Results and Recent Corporate Developments on Tuesday, November 13",Business Wire
Nov-13-18,Edited Transcript of CATB earnings conference call or presentation 13-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Nov-13-18,Catabasis Pharmaceuticals: 3Q Earnings Snapshot,Associated Press
Nov-13-18,Catabasis Pharmaceuticals Reports Third Quarter 2018 Financial Results and Reviews Business Progress,Business Wire
Nov-13-18,Catabasis Pharmaceuticals Announces Collaboration with the University of Texas Southwestern to Explore the Potential Benefits of Edasalonexent on Cardiac Function in Duchenne and Becker Muscular Dystrophies,Business Wire
Nov-15-18,Does The Catabasis Pharmaceuticals Inc (NASDAQ:CATB) Share Price Fall With The Market?,Simply Wall St.
Nov-16-18,Edited Transcript of CATB earnings conference call or presentation 13-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Nov-27-18,Catabasis Pharmaceuticals Announces Publication of Phase 1 Clinical Results of Edasalonexent (CAT-1004) in Duchenne Muscular Dystrophy,Business Wire
Nov-28-18,"Consolidated Research: 2018 Summary Expectations for MyoKardia, Bristow Group, The Chefs' Warehouse, Catabasis Pharmaceuticals, Casa, and EP Energy  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Dec-18-18,Catella Divests Card Issuing Operations in Luxembourg to Advanzia Bank and Completes Strategic Review,PR Newswire
Dec-24-18,Catabasis Pharmaceuticals Announces Reverse Stock Split,Business Wire
Dec-31-18,"Why Canada Goose Holdings, Catabasis Pharmaceuticals, and Globalstar Jumped Today",Motley Fool
Jan-03-19,Catabasis Pharmaceuticals Phase 3 PolarisDMD Clinical Trial for Edasalonexent in Duchenne Muscular Dystrophy Progress Update and Additional Trial Sites Open for Enrollment,Business Wire
Jan-04-19,Catabasis Pharmaceuticals Appoints Gregg Lapointe to its Board of Directors,Business Wire
Jan-08-19,Agenus (AGEN) Surges: Stock Moves 9.4% Higher,Zacks
Jan-11-19,Is Catabasis Pharmaceuticals (CATB) Outperforming Other Medical Stocks This Year?,Zacks
Jan-14-19,Catabasis Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?,Zacks
Jan-15-19,"Is Catabasis Pharmaceuticals, Inc.s (NASDAQ:CATB) CEO Overpaid Relative To Its Peers?",Simply Wall St.
